Objective:To investigate the chronic disease management mode for stable stage of chronic obstructive pulmonary disease（COPD）

and to analyze the effect of family doctor contract service on the management value of this mode and acute exacerbation risk.Methods:A total of 46 patients with COPD who were admitted to our hospital from September 2019 to March 2020 were randomly divided into intervention group and control group

name

age

sex

smoking

and occupation were recorded for each patient

and St.George’s Respiratory Questionnaire（SGRQ） score

modified Medical Research Council（mMRC） score

forced expiratory volume in 1 second（FEV1）

forced vital capacity（FVC）

and FEV1/FVC ratio were determined for each patient.Both groups were given cough-relieving

phlegm-expelling

and spasmolytic drugs

and the patients in the intervention group were given intervention measures.Network informatization was used to establish the family archives for COPD patients

and regular follow-up was performed to monitor patients’ health data archives.After 6 months of the experiment

SGRQ score

mMRC score

FEV1

FVC

and FEV1/FVC ratio were recorded for each patient again.Results:There were no significant differences in age

sex

and smoking between the control group and the intervention group（P> 0.05）.There were no significant differences in SGRQ and mMRC scores between the control group and the intervention group before and after treatment（P> 0.05）.During management treatment

the intervention group had a significantly lower incidence rate of acute exacerbation risk than the control group（P <0.05）.There were no significant differences in FEV1

FVC

and FEV1/FVC ratio between the control group and the intervention group before and after treatment（P> 0.05）.Conclusion:For patients with stable stage of COPD

family doctor contract service can provide standardized guidance for self-management and pulmonary rehabilitation

give suggestions on self-management

encourage them to respond quickly to the symptoms of disease deterioration

and reduce adverse events and the risk of poor prognosis.